Eisai's Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China
- Written by ACN Newswire - Press Releases
TOKYO, Jan 6, 2020 - (JCN Newswire) - Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic name perampanel) for use in the adjunctive treatment of partial-onset seizures (with or without secondarily generalized seizures) in epilepsy patients 12 years of age and older.In China, it is
Read more //?#